For the world’s wealthiest donors, there is usually a seductive lure to solving systemic problems. From the tech moguls of Silicon Valley seeking moonshots to massive foundations targeting poverty and climate change, big philanthropy thrives on high-stakes, transformative goals. However, a critical gap has emerged in this landscape known as One Health. This interdisciplinary approach recognizes that human, animal, and environmental health are inextricably linked, meaning a virus in a bat or deforestation in a rainforest isn’t just an ecological issue but a direct threat to global health security.

The financial logic for investing in One Health is staggering. According to World Bank estimates, spending around eleven billion dollars annually on prevention guided by these principles is far more efficient than spending over thirty billion every year to manage active pandemics. When compared to the trillions lost during the COVID-19 era, the cost of prevention is essentially a rounding error. Despite this, there is no single billionaire champion or flagship foundation treating One Health with the same urgency as carbon capture or vaccine distribution. Instead, funding remains fragmented and secondary.

The primary obstacle is that One Health refuses to fit into the neat silos that donors love. Traditional philanthropy prefers clear metrics such as the number of schools built or vaccines administered because these provide tangible proof of success. One Health operates differently; its ultimate victory is an event that never happens. A pandemic stopped at the animal-human interface produces no dramatic photographs and creates no quarterly statistics of lives saved because those lives were never put at risk in the first place.

This invisibility leads to what experts call a cycle of panic and neglect. Resources flood in immediately following a global catastrophe but evaporate once the immediate fear subsides. While organizations like the World Health Organization and other UN agencies have already established joint plans of action to combat zoonotic threats and antimicrobial resistance, they lack the scaled financing necessary for true implementation. Until philanthropy learns how to value the silence of a disaster averted, one of the most effective tools for planetary survival will remain an expensive blind spot.